'Repair mutation' identified in case of EBS


Dundee, Scotland - A routine cell culture of a patient with epidermolysis bullosa simplex (EBS) has led to the inadvertent discovery of a revertant mutation that deactivates the original pathogenic mutation, according to Irwin McLean, Ph.D.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.